Status:
UNKNOWN
Validation of Addition of Uterine Fluid to Human Embryo Culture Medium
Lead Sponsor:
IVI Murcia
Collaborating Sponsors:
Universidad de Murcia
Conditions:
Infertility
Eligibility:
All Genders
18-39 years
Brief Summary
Infertility or infertility affects about 15% of couples of reproductive age. It is estimated that 80 million people around the world suffer from this problem. Assisted reproduction techniques (ART) us...
Detailed Description
1. Creation of the first collection of human uterine fluid samples for Assisted Reproduction use. Female reproductive system will be collected at the Virgen de la Arrixaca University Clinical Hospital...
Eligibility Criteria
Inclusion
- Couples in icsi treatment
- Woman:
- BMI between 17 and 30.Under controlled ovarian stimulation and at least 8 metaphase II oocytes collected
- Man:
- Sperm concentration higher than 5 million sperm / ml
Exclusion
- Woman:
- Diagnosis of endometriosis Uterine pathology that compromises embryonic development Patients undergoing treatment for repeat abortion or implantation failures Abnormal karyotype Patients included in the Pre-Implantation Genetic Diagnosis (DPI) program
- Male:
- Men whit abnormal karyotype, High values of DNA fragmentation Abnormal FISH (Fluorescence in situ Hybridization) Sperm from epididymal aspirate or testicular biopsy
Key Trial Info
Start Date :
January 30 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT03436758
Start Date
January 30 2018
End Date
December 31 2019
Last Update
February 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IVI Murcia
Murcia, Spain, 30007